Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Carstens, Jan ^a   Grønbæk, Henning ^a   Larsen, Helle K ^a   Pedersen, Erling B ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CYCLIC GMP; DIURETIC AGENT; FUROSEMIDE; PLACEBO; RENIN; SODIUM; SODIUM CHLORIDE; SPIRONOLACTONE; URODILATIN;

ADULT; ALCOHOL LIVER DISEASE; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; ASCITES; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURETIC ACTIVITY; DRUG INFUSION; DRUG MECHANISM; DRUG POTENCY; FEMALE; HEART RATE; HUMAN; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LOW DRUG DOSE; MALE; MICTURITION; NATRIURESIS; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL; REHYDRATION; SECOND MESSENGER; SHORT COURSE THERAPY; SIDE EFFECT; SINGLE BLIND PROCEDURE; SODIUM ABSORPTION; SODIUM BLOOD LEVEL; SODIUM RETENTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CROSS-OVER STUDIES; DIURETICS; FEMALE; HUMANS; KIDNEY TUBULES, PROXIMAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NATRIURESIS; PEPTIDE FRAGMENTS; RENIN; SODIUM;

EID: 33846940704     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-1     Document Type: Article

References (17)

1. Schrier RW Arroyo V Bernardi M Epstein M Henriksen JH Rodés J Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis Hepatology 1988 5 1151-1157
2. Epstein M Hepatorenal syndrome: Emerging perspectives of pathophysiology and therapy J Am Soc Nephrol 1994 4 1735-1753 8068872
3. Arroyo V Ginès P Gerbes AL Dudley FJ Gentilini P Laffi G Reynolds TB Ring-Larsen H Scholmerich J Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Hepatology 1996 1 164-176 10.1002/hep.510230122
4. Brenner BM Ballermann BJ Gunning ME Zeidel ML Diverse biological actions of atrial natriuretic peptide Physiol Rev 1990 3 665-699
5. Beutler JJ Koomans HA Rabelink TJ Gaillard CA Van Hattum J Boer P Dorhout Mees EJ Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis Hepatology 1989 2 148-153 1989
6. Petrillo A Scherrer U Gonvers JJ Nussberger J Marder H de Vane P Waeber B Hofstetter JR Brunner HR Atrial natriuretic peptide administration as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites J Cardiovasc Pharmacol 1988 3 279-285
7. Brenard R Moreau R Pussard E Champigneulle B Gaudin C Hadengue A Braillon A Lebrec D Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis J Hepatol 1992 14 347-356 10.1016/0168-8278(92)90182-O 1386858
8. Carstens J Jensen KT Pedersen EB Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones Clin Sci 1997 92 397-407 9176040
9. Carstens J Jensen KT Pedersen EB Metabolism and action of urodilatin infusion in healthy volunteers Clin Pharmacol Ther 1998 64-73 86 10.1016/ S0009-9236(98)90025-X 9695722
10. Saxenhofer H Fitzgibbon WR Paul RV Urodilatin: Binding properties and stimulation of cGMP generation in rat kidney cells Am J Physiol 1993 264 F267-273 8095370
11. Schulz-Knappe P Forssmann K Herbst F Hock D Pipkorn R Forssmann WG Isolation and structural analysis of urodilatin, a new peptide of the cardiodilati-(ANP)-family, extracted from human urine Klin Wochenschr 1988 66 752-759 10.1007/BF01726570 2972874
12. Greenwald JE Needlemann P Wilkins MR Schreiner GF Renal synthesis of atriopeptin-like protein in physiology and pathophysiology Am J Physiol 1991 260 F602-607 1826411
13. Salo J Jimenez W Kuhn M Gines A Gines P Fernandez-Esparrach G Angeli P Claria J Bataller R Arroyo V Forssmann WG Rodes J Urinary excretion of urodilatin in patients with cirrhosis Hepatology 1996 24 1428-1432 10.1002/hep.510240621 8938175
14. Carstens J Greisen J Jensen KT Vilstrup H Pedersen EB Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites J Am Soc Nephrol 1998 9 1489-1498 9697672
15. Meyer M Pfarr E Schirmer G Uberbacher HJ Schope K Bohm E Fluge T Mentz P Scigalla P Forssmann WG Therapeutic use of the natriuretic peptide ularitide in acute renal failure Ren Fail 1999 21 85-100 10048120
16. Langrehr JM Kahl A Meyer M Neumann U Knoop M Jonas S Steinmuller T Bechstein WO Frei U Forsmann WG Neuhaus P Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: A randomized placebo-controlled study Clin Transplant 1997 11 593-598 9408691
17. Mitrovic V Lüss H Nitsche K Forssmann K Maronde E Fricke K Forsmann WG Meyer M Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: A double-blind, placebo-controlled, ascending-dose trial Am Heart J 2005 150 1239e1-1239e8 10.1016/j.ahj.2005.01.022